These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 25889879)

  • 21. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
    Wu PJ; Hung YF; Liu HY; Hsueh YP
    Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
    Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
    Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
    Solberg NO; Chamberlin R; Vigil JR; Deck LM; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Bisoffi M; Severns V; Vander Jagt DL; Sillerud LO
    J Alzheimers Dis; 2014; 40(1):191-212. PubMed ID: 24413613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
    Heneka MT; Nadrigny F; Regen T; Martinez-Hernandez A; Dumitrescu-Ozimek L; Terwel D; Jardanhazi-Kurutz D; Walter J; Kirchhoff F; Hanisch UK; Kummer MP
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6058-63. PubMed ID: 20231476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model.
    Park TS; Ryu YK; Park HY; Kim JY; Go J; Noh JR; Kim YH; Hwang JH; Choi DH; Oh WK; Lee CH; Kim KS
    Int J Mol Med; 2017 Jan; 39(1):21-30. PubMed ID: 28004107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
    Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
    Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil improves learning and memory deficits in APP/PS1 mice by inhibition of microglial activation.
    Guo HB; Cheng YF; Wu JG; Wang CM; Wang HT; Zhang C; Qiu ZK; Xu JP
    Neuroscience; 2015 Apr; 290():530-42. PubMed ID: 25662507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer's Disease.
    Manocha G; Ghatak A; Puig K; Combs C
    Curr Alzheimer Res; 2018; 15(12):1123-1135. PubMed ID: 30068274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells).
    Nagamoto-Combs K; Combs CK
    J Neurosci; 2010 Jul; 30(28):9641-6. PubMed ID: 20631193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
    Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
    J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
    Krauthausen M; Kummer MP; Zimmermann J; Reyes-Irisarri E; Terwel D; Bulic B; Heneka MT; Müller M
    J Clin Invest; 2015 Jan; 125(1):365-78. PubMed ID: 25500888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TREM1 facilitates microglial phagocytosis of amyloid beta.
    Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
    Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.